Skip to main content
Equibles
SRRK logo

SRRK · Scholar Rock Holding Corp · Webcasts, Transcripts & Audio

Track SRRK — free

Use SRRK with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SRRK.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$43.40 -3.41 (-7.28%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$5.92B
Shares
121.79M
Volume · Oct 5 3.35M Avg daily vol (3M) 1.46M

Scholar Rock Holding Corp Webcasts

Earnings calls, investor updates, investor days and conferences for Scholar Rock Holding Corp (SRRK), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Conference
Investor event
2026-08-12
Scholar Rock Holding Corp (SRRK) August 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Scholar Rock Holding Corp (SRRK) Q2 2026 Earnings Call Transcript
Confident tone FDA review and PDUFA European MAA and launch readiness FSHD program (FORGE study)
Diluted EPS
$-0.84
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-06-09
Scholar Rock Holding Corp (SRRK) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Scholar Rock Holding Corp (SRRK) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-07
Scholar Rock Holding Corp (SRRK) Q1 2026 Earnings Call Transcript
Confident tone FDA acceptance and PDUFA timeline for apitegromab BLA SMA launch readiness and patient population Anti-myostatin pipeline expansion beyond SMA
Revenue
$
Diluted EPS
$-0.83
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Scholar Rock Holding Corp (SRRK) Q4 2025 Earnings Call Transcript
Confident tone SMA commercial launch readiness SRK-439 and subQ formulation progress FSHD Phase 2 (FORGE) development
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-14
Scholar Rock Holding Corp (SRRK) Q3 2025 Earnings Call Transcript
Positive tone SMA commercial opportunity FDA / Novo Nordisk Bloomington facility Apitegromab CRL and regulatory path
Diluted EPS
$-0.90
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Scholar Rock Holding Corp (SRRK) Q2 2025 Earnings Call Transcript
Confident tone Apitegromab regulatory approvals and commercial launch Apitegromab clinical profile in SMA FDA review and CDMO inspections
Diluted EPS
$-0.98
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-14
Scholar Rock Holding Corp (SRRK) Q1 2025 Earnings Call Transcript
Confident tone Apitegromab for SMA SRK-439 development Regulatory progress and launch
Diluted EPS
$-0.67
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Scholar Rock Holding Corp (SRRK) Q4 2024 Earnings Call Transcript
Confident tone SRK-439 anti-myostatin development Apitegromab SAPPHIRE trial results Regulatory submissions and milestones
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Scholar Rock Holding Corp (SRRK) Q3 2024 Earnings Call Transcript
Confident tone Apitegromab efficacy and safety SAPPHIRE Phase 3 results SRK-439 cardiometabolic/obesity pipeline
Diluted EPS
$-0.66
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-08
Scholar Rock Holding Corp (SRRK) Q2 2024 Earnings Call Transcript
Confident tone SRK-439 / EMBRAZE in obesity Apitegromab SAPPHIRE Phase 3 readout TOPAZ long-term data
Diluted EPS
$-0.60
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Scholar Rock Holding Corp (SRRK) Q1 2024 Earnings Call
Diluted EPS
$-0.59
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-01-08
Scholar Rock Holding Corp (SRRK) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Scholar Rock Holding Corp (SRRK) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.53
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Scholar Rock Holding Corp (SRRK) Q2 2023 Earnings Call
Diluted EPS
$-0.47
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-09
Scholar Rock Holding Corp (SRRK) Q1 2023 Earnings Call
Diluted EPS
$-0.49
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-07
Scholar Rock Holding Corp (SRRK) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Scholar Rock Holding Corp (SRRK) Q3 2022 Earnings Call
Diluted EPS
$-0.55
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-08
Scholar Rock Holding Corp (SRRK) Q2 2022 Earnings Call
Diluted EPS
$-1.06
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-16
Scholar Rock Holding Corp (SRRK) Q1 2022 Earnings Call
Revenue
$33.19M
▲ 605% YoY
Diluted EPS
$-0.21
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-07
Scholar Rock Holding Corp (SRRK) Q4 2021 Earnings Call
Revenue
$4.05M*
▲ 17.8% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q2
2020-08-07
Scholar Rock Holding Corp (SRRK) Q2 2020 Earnings Call Transcript
Revenue
$3.90M
▼ 22.6% YoY
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–23 of 23 webcasts
Key facts CIK 1727196 CUSIP 80706P103 13F (30d) 7 filings 6 filers Visit website Investor relations